RxSight, Inc. to Present at the Wells Fargo Healthcare Conference
RxSight, Inc. (NASDAQ: RXST), a medical device company focused on enhancing vision post-cataract surgery, will participate in the Wells Fargo Healthcare Conference on September 8, 2022, at 8:35 a.m. PT / 11:35 a.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
RxSight, Inc. (NASDAQ: RXST), a medical device company focused on enhancing vision post-cataract surgery, will participate in the Wells Fargo Healthcare Conference on September 8, 2022, at 8:35 a.m. PT / 11:35 a.m. ET. The event will feature a fireside chat with management, and interested parties can access a live and archived webcast through their investor relations website.
RxSight specializes in innovative lens technology, including the RxSight Light Adjustable Lens system, which allows doctors to tailor visual acuity for patients after cataract procedures.
Details
News Market Reaction – RXST
The recorded move for RXST in the trading session of this news was +3.11%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ALISO VIEJO, Calif., Aug. 24, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate in the upcoming Wells Fargo Healthcare Conference.
RxSight’s management is scheduled to participate in a fireside chat Thursday, September 8, 2022, at 8:35 a.m. Pacific Time / 11:35 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation at: https://investors.rxsight.com/.
About RxSight, Inc.
RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.
Company Contact:
Shelley Thunen
RxSight, Inc.
949-521-7830
sthunen@rxsight.com
Investor Relations Contact:
ir@rxsight.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.